# Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain

> **NCT03891264** · PHASE4 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 7 (actual)

## Conditions studied

- Back Pain, Low

## Interventions

- **DRUG:** Cannabidiol

## Key facts

- **NCT ID:** NCT03891264
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-13
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Funding obtained to do a larger placebo-controlled trial
- **Last updated:** 2022-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03891264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03891264, "Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03891264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*